X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs IPCA LABS - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. IPCA LABS WOCKHARDT LTD./
IPCA LABS
 
P/E (TTM) x 18.3 27.7 66.1% View Chart
P/BV x 1.9 2.1 87.8% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 WOCKHARDT LTD.   IPCA LABS
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-16
IPCA LABS
Mar-17
WOCKHARDT LTD./
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs2,000643 311.0%   
Low Rs706503 140.4%   
Sales per share (Unadj.) Rs403.7254.4 158.7%  
Earnings per share (Unadj.) Rs29.516.1 183.4%  
Cash flow per share (Unadj.) Rs42.429.8 142.3%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs323.4194.6 166.2%  
Shares outstanding (eoy) m110.51126.20 87.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.42.3 148.8%   
Avg P/E ratio x45.935.7 128.8%  
P/CF ratio (eoy) x31.919.2 166.0%  
Price / Book Value ratio x4.22.9 142.1%  
Dividend payout %06.2 0.0%   
Avg Mkt Cap Rs m149,50972,300 206.8%   
No. of employees `0007.413.3 55.4%   
Total wages/salary Rs m9,4436,960 135.7%   
Avg. sales/employee Rs Th6,048.62,413.5 250.6%   
Avg. wages/employee Rs Th1,280.2523.2 244.7%   
Avg. net profit/employee Rs Th441.5152.4 289.6%   
INCOME DATA
Net Sales Rs m44,61432,106 139.0%  
Other income Rs m970226 429.6%   
Total revenues Rs m45,58432,332 141.0%   
Gross profit Rs m5,0384,448 113.3%  
Depreciation Rs m1,4261,730 82.4%   
Interest Rs m1,012241 420.3%   
Profit before tax Rs m3,5702,703 132.1%   
Minority Interest Rs m-650-   
Prior Period Items Rs m60-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m255675 37.7%   
Profit after tax Rs m3,2572,028 160.6%  
Gross profit margin %11.313.9 81.5%  
Effective tax rate %7.125.0 28.6%   
Net profit margin %7.36.3 115.6%  
BALANCE SHEET DATA
Current assets Rs m39,90617,340 230.1%   
Current liabilities Rs m18,4239,559 192.7%   
Net working cap to sales %48.224.2 198.7%  
Current ratio x2.21.8 119.4%  
Inventory Days Days90100 89.9%  
Debtors Days Days9857 172.7%  
Net fixed assets Rs m35,83220,779 172.4%   
Share capital Rs m553252 218.9%   
"Free" reserves Rs m30,37024,499 124.0%   
Net worth Rs m35,73924,553 145.6%   
Long term debt Rs m16,5423,517 470.3%   
Total assets Rs m79,52239,595 200.8%  
Interest coverage x4.512.2 37.0%   
Debt to equity ratio x0.50.1 323.1%  
Sales to assets ratio x0.60.8 69.2%   
Return on assets %5.45.7 93.7%  
Return on equity %9.18.3 110.3%  
Return on capital %8.710.5 82.5%  
Exports to sales %11.648.6 23.9%   
Imports to sales %4.514.2 31.3%   
Exports (fob) Rs m5,17715,617 33.1%   
Imports (cif) Rs m1,9904,571 43.5%   
Fx inflow Rs m7,58915,617 48.6%   
Fx outflow Rs m2,8785,828 49.4%   
Net fx Rs m4,7119,790 48.1%   
CASH FLOW
From Operations Rs m7162,764 25.9%  
From Investments Rs m-8,182-1,432 571.5%  
From Financial Activity Rs m2,543-1,591 -159.8%  
Net Cashflow Rs m-4,923-259 1,902.3%  

Share Holding

Indian Promoters % 74.5 45.9 162.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 11.4 20.2%  
FIIs % 7.7 25.3 30.4%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 17.4 88.5%  
Shareholders   67,757 36,892 183.7%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   STERLING BIOTECH  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA LTD  NOVARTIS  

Compare WOCKHARDT LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Flat Finish to the Week; Cadila Healthcare Rallies 7%(Closing)

Indian share markets finished marginally higher for the week in a thin trade amid buying in pharma stocks, software stocks and capital good stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Aug 24, 2017 03:36 PM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS